Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David C. Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); and United States Government (USG)/CoVPN Biostatistics Teams
doi: https://doi.org/10.1101/2021.08.09.21261290

Article Information

doi 
https://doi.org/10.1101/2021.08.09.21261290
History 
  • August 12, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Peter B. Gilbert, Ph.D.*,1,*,
  2. David C. Montefiori, Ph.D.*,4,5,
  3. Adrian McDermott, Ph.D.*,2,
  4. Youyi Fong, Ph.D.1,
  5. David C. Benkeser, Ph.D.6,
  6. Weiping Deng, Ph.D.9,
  7. Honghong Zhou, Ph.D.9,
  8. Christopher R. Houchens, Ph.D.7,
  9. Karen Martins, Ph.D.7,
  10. Lakshmi Jayashankar, Ph.D.7,
  11. Flora Castellino, M.D.7,
  12. Britta Flach, Ph.D.2,
  13. Bob C. Lin, B.S.2,
  14. Sarah O’Connell, M.S.2,
  15. Charlene McDanal, B.S.4,5,
  16. Amanda Eaton, M.B.A.4,5,
  17. Marcella Sarzotti-Kelsoe, Ph.D.4,5,
  18. Yiwen Lu, M.S.1,
  19. Chenchen Yu, M.S.1,
  20. Bhavesh Borate, M.B.B.S.1,
  21. Lars W. P. van der Laan, M.A.1,
  22. Nima Hejazi, M.S.8,
  23. Chuong Huynh, M.S.7,
  24. Jacqueline Miller, M.D.9,
  25. Hana M. El Sahly, M.D.10,
  26. Lindsey R. Baden, M.D.11,
  27. Mira Baron, M.D.12,
  28. Luis De La Cruz, M.D.13,
  29. Cynthia Gay, M.D.14,
  30. Spyros Kalams, M.D.15,
  31. Colleen F. Kelley, M.D., M.P.H.16,
  32. Mark Kutner, M.D.17,
  33. Lawrence Corey, M.D.1,
  34. Kathleen M. Neuzil, M.D.18,
  35. Lindsay N. Carpp, Ph.D.1,
  36. Rolando Pajon, Ph.D.9,
  37. Dean Follmann, Ph.D.3,
  38. Ruben O. Donis, Ph.D.£,7,
  39. Richard A. Koup, M.D.£,2 and
  40. on behalf of the Immune Assays; Moderna, Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); and United States Government (USG)/CoVPN Biostatistics Teams
  1. 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
  2. 2Vaccine Research Center
  3. 3Biostatistics Research Branch
  4. 4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
  5. 5Department of Surgery and Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
  6. 6Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA
  7. 7Biomedical Advanced Research and Development Authority, Washington, DC
  8. 8Graduate Group in Biostatistics, University of Berkeley, Berkeley, CA
  9. 9Moderna, Inc., Cambridge, MA
  10. 10Baylor College of Medicine, Houston, TX
  11. 11Brigham and Women’s Hospital, Boston, MA
  12. 12Palm Beach Research Center, West Palm Beach, FL
  13. 13Keystone Vitalink Research, Greenville, SC
  14. 14University of North Carolina, Chapel Hill, NC
  15. 15Vanderbilt University Medical Center, Nashville, TN
  16. 16Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and the Grady Health System, Atlanta, GA
  17. 17Suncoast Research Group, Miami, FL
  18. 18Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
  1. ↵*Corresponding author; email: pgilbert{at}fredhutch.org

  1. ↵* Drs. Peter B. Gilbert, David C. Montefiori, and Adrian McDermott contributed equally to this work.

  2. ↵£ Drs. Ruben O. Donis and Richard A. Koup contributed equally to this work.

Back to top
Posted August 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial
Peter B. Gilbert, David C. Montefiori, Adrian McDermott, Youyi Fong, David C. Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Kelley, Mark Kutner, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajon, Dean Follmann, Ruben O. Donis, Richard A. Koup
medRxiv 2021.08.09.21261290; doi: https://doi.org/10.1101/2021.08.09.21261290
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area